Compare MBBC & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MBBC | MYO |
|---|---|---|
| Founded | 1902 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.5M | 36.9M |
| IPO Year | N/A | 2017 |
| Metric | MBBC | MYO |
|---|---|---|
| Price | $12.73 | $0.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 3.4K | ★ 566.2K |
| Earning Date | 02-22-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | $7,299,708.00 | ★ $41,643,203.00 |
| Revenue This Year | N/A | $24.07 |
| Revenue Next Year | N/A | $17.48 |
| P/E Ratio | $111.00 | ★ N/A |
| Revenue Growth | 7.77 | ★ 65.00 |
| 52 Week Low | $8.74 | $0.71 |
| 52 Week High | $12.89 | $6.44 |
| Indicator | MBBC | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 61.26 | 42.51 |
| Support Level | $12.28 | $0.92 |
| Resistance Level | $12.87 | $1.02 |
| Average True Range (ATR) | 0.26 | 0.07 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 87.05 | 10.98 |
Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).